EBS
Emergent Biosolutions Inc
NYSE: EBS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$8.23
+3.00% today
Updated 2026-04-30
Market cap
$414.70M
P/E ratio
8.63
P/S ratio
0.56x
EPS (TTM)
$0.93
Dividend yield
—
52W range
$5 – $14
Volume
0.9M
Emergent Biosolutions Inc (EBS) Insider transactions
Net insider activity
Net buying (2,405,763 shares)
Buy transactions
45
Sell transactions
55
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-01 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Sale | 4,000 | $8.44 | $33760.00 |
| 2026-03-05 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Sale | 9,397 | $8.44 | $79310.68 |
| 2026-03-05 | PERL, JESSICA | SVP, General Counsel, Corp Sec | Sale | 6,465 | $8.44 | $54564.60 |
| 2026-03-05 | PAPA, JOSEPH C | Director, President and CEO | Sale | 37,055 | $8.44 | $312744.20 |
| 2026-03-05 | LOWRY, SIMON C | SVP, R&D, CMO | Sale | 10,636 | $8.44 | $89767.84 |
| 2026-03-05 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 23,650 | $8.44 | $199606.00 |
| 2026-03-05 | HARTZEL, WILLIAM | SVP, Bioservices | Sale | 9,493 | $8.44 | $80120.92 |
| 2026-03-05 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 8,199 | $8.44 | $69199.56 |
| 2026-03-03 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Buy | 44,834 | — | — |
| 2026-03-03 | PERL, JESSICA | SVP, General Counsel, Corp Sec | Buy | 46,702 | — | — |
| 2026-03-03 | PAPA, JOSEPH C | Director, President and CEO | Buy | 252,194 | — | — |
| 2026-03-03 | LOWRY, SIMON C | SVP, R&D, CMO | Buy | 44,834 | — | — |
| 2026-03-03 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Buy | 72,856 | — | — |
| 2026-03-03 | HARTZEL, WILLIAM | SVP, Bioservices | Buy | 44,834 | — | — |
| 2026-03-03 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Buy | 44,834 | — | — |
| 2026-03-03 | FOWLER, JOHN D JR | Director | Buy | 5,006 | $8.99 | $45003.94 |
| 2026-03-01 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Sale | 116 | $8.15 | $945.40 |
| 2026-03-01 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 683 | $8.15 | $5566.45 |
| 2026-03-01 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 313 | $8.15 | $2550.95 |
| 2026-02-25 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 20,321 | — | — |
| 2026-02-09 | PERL, JESSICA | SVP, General Counsel, Corp Sec | Sale | 918 | $11.03 | $10125.54 |
| 2026-02-06 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Sale | 8,655 | $10.92 | $94512.60 |
| 2026-02-06 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Sale | 1,022 | $10.92 | $11160.24 |
| 2026-02-06 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 46,155 | $10.92 | $504012.60 |
| 2026-02-06 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 5,642 | $10.92 | $61610.64 |
| 2026-02-06 | HARTZEL, WILLIAM | SVP, Bioservices | Sale | 5,771 | $10.92 | $63019.32 |
| 2026-02-06 | HARTZEL, WILLIAM | SVP, Bioservices | Sale | 630 | $10.92 | $6879.60 |
| 2026-02-06 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 28,847 | $10.92 | $315009.24 |
| 2026-02-06 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 2,852 | $10.92 | $31143.84 |
| 2025-12-14 | LOWRY, SIMON C | SVP, R&D, CMO | Sale | 3,543 | $11.41 | $40425.63 |
| 2025-12-05 | RICHARD, RONALD | Director | Sale | 25,748 | — | — |
| 2025-12-05 | RICHARD, RONALD | Director | Buy | 25,748 | $5.02 | $129254.96 |
| 2025-12-05 | RICHARD, RONALD | Director | Sale | 14,884 | $11.90 | $177086.86 |
| 2025-12-05 | RICHARD, RONALD | Director | Sale | 10,864 | $11.90 | $129257.70 |
| 2025-12-05 | RICHARD, RONALD | Director | Sale | 7,100 | $12.11 | $85990.23 |
| 2025-11-11 | HARTZEL, WILLIAM | SVP, Bioservices | Sale | 610 | $10.88 | $6636.80 |
| 2025-11-10 | DEGOLYER, DONALD W | Director | Sale | 17,801 | $10.54 | $187622.54 |
| 2025-11-07 | DAYAL, SUJATA TYAGI | Director | Sale | 8,552 | $10.00 | $85520.00 |
| 2025-10-15 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 4,995 | $9.60 | $47952.00 |
| 2025-10-07 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 30,608 | $10.00 | $306080.00 |
| 2025-08-15 | ZOON, KATHRYN C | Director | Sale | 7,086 | $8.87 | $62852.82 |
| 2025-08-12 | DEGOLYER, DONALD W | Director | Sale | 7,844 | $8.65 | $67830.99 |
| 2025-07-11 | HARTZEL, WILLIAM | SVP, Bioservices | Sale | 4,263 | $7.36 | $31375.68 |
| 2025-06-08 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Sale | 464 | $6.63 | $3076.32 |
| 2025-06-08 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 2,733 | $6.63 | $18119.79 |
| 2025-06-08 | HARTZEL, WILLIAM | SVP, Bioservices | Sale | 1,167 | $6.63 | $7737.21 |
| 2025-06-08 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 1,249 | $6.63 | $8280.87 |
| 2025-05-23 | KATKIN, KEITH | Director | Sale | 7,844 | $6.30 | $49417.20 |
| 2025-05-13 | PAPA, JOSEPH C | Director, President and CEO | Buy | 60,000 | $5.83 | $349800.00 |
| 2025-05-07 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 19,963 | — | — |
| 2025-04-30 | ZOON, KATHRYN C | Director | Buy | 15,824 | — | — |
| 2025-04-30 | ZOON, KATHRYN C | Director | Buy | 34,403 | — | — |
| 2025-04-30 | WHITE, MARVIN L | Director | Buy | 15,824 | — | — |
| 2025-04-30 | WHITE, MARVIN L | Director | Buy | 34,403 | — | — |
| 2025-04-30 | SULLIVAN, LOUIS W | Director | Buy | 15,824 | — | — |
| 2025-04-30 | SULLIVAN, LOUIS W | Director | Buy | 34,403 | — | — |
| 2025-04-30 | RICHARD, RONALD | Director | Buy | 15,824 | — | — |
| 2025-04-30 | RICHARD, RONALD | Director | Buy | 34,403 | — | — |
| 2025-04-30 | KATKIN, KEITH | Director | Buy | 15,824 | — | — |
| 2025-04-30 | KATKIN, KEITH | Director | Buy | 34,403 | — | — |
| 2025-04-30 | HARSANYI, ZSOLT | Director, Chairman | Buy | 15,824 | — | — |
| 2025-04-30 | HARSANYI, ZSOLT | Director, Chairman | Buy | 34,403 | — | — |
| 2025-04-30 | FOWLER, NEAL FRANKLIN | Director | Buy | 15,824 | — | — |
| 2025-04-30 | FOWLER, NEAL FRANKLIN | Director | Buy | 34,403 | — | — |
| 2025-04-30 | DEGOLYER, DONALD W | Director | Buy | 15,824 | — | — |
| 2025-04-30 | DEGOLYER, DONALD W | Director | Buy | 34,403 | — | — |
| 2025-04-30 | DAYAL, SUJATA TYAGI | Director | Buy | 15,824 | — | — |
| 2025-04-30 | DAYAL, SUJATA TYAGI | Director | Buy | 34,403 | — | — |
| 2025-04-07 | HARTZEL, WILLIAM | SVP, Bioservices | Sale | 561 | $4.44 | $2490.84 |
| 2025-04-07 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 480 | $4.44 | $2131.20 |
| 2025-03-12 | ZOON, KATHRYN C | Director | Sale | 10,000 | $5.73 | $57300.00 |
| 2025-03-12 | PAPA, JOSEPH C | Director, President and CEO | Buy | 250,000 | — | — |
| 2025-03-12 | FOWLER, NEAL FRANKLIN | Director | Sale | 35,000 | $5.83 | $204050.00 |
| 2025-03-06 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Buy | 62,500 | — | — |
| 2025-03-06 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Buy | 62,500 | — | — |
| 2025-03-06 | PERL, JESSICA | SVP, General Counsel, Corp Sec | Buy | 62,500 | — | — |
| 2025-03-06 | PERL, JESSICA | SVP, General Counsel, Corp Sec | Buy | 62,500 | — | — |
| 2025-03-06 | PAPA, JOSEPH C | Director, President and CEO | Buy | 282,500 | — | — |
| 2025-03-06 | PAPA, JOSEPH C | Director, President and CEO | Buy | 282,500 | — | — |
| 2025-03-06 | LOWRY, SIMON C | SVP, R&D, CMO | Buy | 62,500 | — | — |
| 2025-03-06 | LOWRY, SIMON C | SVP, R&D, CMO | Buy | 62,500 | — | — |
| 2025-03-06 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Buy | 178,546 | — | — |
| 2025-03-06 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Buy | 146,888 | — | — |
| 2025-03-06 | HARTZEL, WILLIAM | SVP, Bioservices | Buy | 62,500 | — | — |
| 2025-03-06 | HARTZEL, WILLIAM | SVP, Bioservices | Buy | 62,500 | — | — |
| 2025-03-06 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Buy | 62,500 | — | — |
| 2025-03-06 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Buy | 62,500 | — | — |
| 2025-03-05 | HARTZEL, WILLIAM | SVP, Bioservices | Sale | 292 | $5.80 | $1693.60 |
| 2025-03-01 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Sale | 116 | $7.48 | $867.68 |
| 2025-03-01 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 683 | $7.48 | $5108.84 |
| 2025-03-01 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 313 | $7.48 | $2341.24 |
| 2025-02-28 | WILLIAMS, PAUL ANTHONY | SVP, Products Business | Sale | 382 | $7.48 | $2857.36 |
| 2025-02-28 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 1,073 | $7.48 | $8026.04 |
| 2025-02-12 | LINDAHL, RICHARD S | EVP, Chief Financial Officer | Sale | 16,916 | — | — |
| 2025-02-12 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 24,078 | — | — |
| 2025-02-12 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 5,913 | — | — |
| 2025-02-09 | PERL, JESSICA | SVP, General Counsel, Corp Sec | Sale | 918 | $10.00 | $9180.00 |
| 2024-12-15 | LOWRY, SIMON C | SVP, R&D, CMO | Buy | 40,499 | — | — |
| 2024-12-15 | LOWRY, SIMON C | SVP, R&D, CMO | Buy | 29,482 | — | — |
| 2024-12-08 | GLESSNER, COLEEN | EVP, Quality & Ethics, and CPL | Sale | 18,674 | $9.01 | $168252.74 |